Stock Analysis · AbbVie Inc (ABBV)
AbbVie is a global drugmaker reshaping itself after Humira’s decline. Newer medicines such as Skyrizi and Rinvoq, plus strong cash generation and a broad specialty portfolio, have restored growth and made the company’s transition worth a closer look.